WHO ICTRP trial
A Multicenter Randomized Controlled Trial of Jiangzhiling Granules in Treating…
ChiCTR2100052333 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100052333 |
|---|---|
| Public title | A Multicenter Randomized Controlled Trial of Jiangzhiling Granules in Treating Abnormal Lipid Metabolism after HAART |
| Scientific title | A Multicenter Randomized Controlled Trial of Jiangzhiling Granules in Treating Abnormal Lipid Metabolism after HAART |
| Primary sponsor | Guangzhou Eighth People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | HIV/AIDS lipid metabolism abnormalities |
| Interventions | experimental group:Jianzhi Ling granule +HAART;control group:Fenofibrate capsule +HAART |
| Registration date | Oct 24, 2021 |
| Target size | experimental group:60;control group:60 |
| Secondary IDs | ChiMCTR2200006307 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: